Bring programmable bioelectric medicine into the workflows where chronic pain is actually managed.
Research and academic partners.
Advance the science of programmable bioelectric medicine alongside the labs and networks defining the field.
Electrome collaborates with universities, translational research labs, clinical trial networks, bioelectric medicine researchers, and neuroscience institutes to investigate signal-to-physiology relationships, run investigator-initiated studies, and contribute to the published evidence base for pulsed shortwave therapy and adjacent modalities.
What partners get
Programmable platform access
Research partners can investigate dose, waveform, and protocol variants on a programmable, cloud-connected applicator built on the FDA-cleared ActiPatch foundation.
AI-native, human-in-the-loop discovery
Pair clinical observation with our discovery engine, which maps how signal profiles modulate ion channels, membrane potentials, and inflammatory pathways across cell types.
Investigator-initiated studies
We support IIS proposals, IRB submission, and protocol design across pain, recovery, infection, brain health, and oncology adjacencies.
Open scientific posture
Findings, including null results, are intended to be published. We hold ourselves to the language the evidence supports.
How partnerships show up
Examples of the partnership shapes that fit this category. Most engagements blend more than one.
Translational pilots
Bench-to-bedside studies that translate cellular and animal-model bioelectric findings into early human use.
Clinical trial networks
Multi-site protocols across academic medical centers and clinical research organizations.
Mechanism studies
Mechanism-of-action work investigating how PSWT modulates inflammation, repair, and pain signaling.
Indication exploration
Pipeline indications including post-surgical recovery, wound healing, neuroinflammation, infection, and oncology adjuncts.
Partner archetypes
The kinds of organizations we partner with in this category. We are happy to share specific named relationships under standard partnership review.
Frequently asked
Reach out via the partnerships team with a one-page concept. We will route it to the relevant clinical and scientific lead for fast review.
Yes, under a research collaboration agreement. We provide programmable units and dose-window controls beyond the consumer commercial profile, scoped to the protocol.
Our clinical science team can assist with endpoint selection, control arms, and prior-evidence summaries to accelerate IRB submission.
Ready to talk?
Tell us a little about the program you have in mind. The partnerships team will route it to the right clinical, commercial, or technical lead.
Other partner categories
Bring FDA-cleared bioelectric pain therapy to the shelves, channels, and platforms where patients already shop for relief.
Build alongside the platform layer connecting pulsed shortwave therapy research to programmable, AI-native, human-in-the-loop infrastructure for bioelectric medicine.
